Bruker opened lower at $60.46, compared with its previous close of $62.41. In the last trading session, the stock traded between $58.68 and $61.40. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Bruker is now worth
$ 73.40
Resulting in a loss of
$ 26.60 (26.60%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 8 Analysts
Buy
37.5%
Hold
50%
Sell
12.5%
Markets Today
Today's Change
$-2.10 (-3.36%)
Day High
$61.40
Day Low
$58.68
Day Open
$60.46
Prev Close
$62.41
Volume
12,23,195
1W Return
-5.50%
1M Return
7.22%
3M Return
5.81%
6M Return
39.39%
1Y Return
44.54%
Fundamentals
Market Cap ($ Mn)
9,211
PE Ratio
-
PB Ratio
3.65
PEG Ratio
-
ROE
-0.40%
ROCE
1.39%
EPS (TTM)
$-0.80
Investment Returns
1 Week
-5.50%
1 Month
7.22%
3 Months
5.81%
6 Months
39.39%
9 Months
42.15%
Financials
Quarterly
All values in $ Mn
797.4
Jun 25
860.5
Sep 25
977.2
Dec 25
823.4
Mar 26
838.5
Jun 26
874.0
Sep 26
Updates
6Nov
Citigroup raises Bruker price target to $64, maintains neutral rating
Citigroup raised Bruker's price target from $53 to $64. Analyst Albert Hu maintained a Neutral rating on the stock. The price target increase reflects a $11 upward revision in valuation.
7 days ago
4Nov
Bruker Q3FY26 Results: Non-GAAP EPS rises 24% YoY to $0.56
Revenue rose 1.6% YoY to $874 million with 0.7% organic growth. Non-GAAP EPS increased 24% to $0.56, beating prior year's $0.45. Operating margin expanded 400 bps to 16.3% due to cost savings and mix. Book-to-bill ratio exceeded one for the fifth consecutive quarter. GAAP loss widened to $0.81 per share following a $175 million goodwill impairment.
8 days ago
21Oct
Bruker to report Q3 2026 earnings on November 4
Bruker Corporation reports Q3 2026 results on November 4, 2026. Conference call scheduled for 8:30 am EDT. Webcast and slide presentation available via investor relations site. Telephone replay accessible until December 4, 2026.
23 days ago
13Oct
TD Cowen maintains Hold on Bruker, lifts price target to $62
TD Cowen raised Bruker Corporation's price target from $60 to $62. The firm maintained a Hold rating on the stock. Analyst Kyle Boucher issued the revised price target.
1mo ago
28Sep
Bruker launches timsUltra AIP and timsOmni proteomics workflows
Bruker introduced timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage and oligonucleotide analysis. MultiDIA-PASEF yielded ~350,000 peptides per sample in Parkinson’s brain tests, identifying ~14,500 protein isoforms. Spectronaut v21 uses AI transfer learning to adapt to new MS capabilities without model redevelopment. timsOmni now supports complete sequence coverage of RNA and DNA via EDD-MS³ workflows.
1mo ago
21Sep
Bruker wins $6M UC Berkeley order for advanced NMR systems
Bruker wins multi-system NMR order from UC Berkeley. Deal value exceeds $6 million with 2027 delivery. Includes AV NEO-X 800 MHz spectrometer with CryoProbe. Upgrades Pines Magnetic Resonance Center infrastructure.
